Envestnet Asset Management
MR

Envestnet Asset Management’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Envestnet Asset Management’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,584
Closed -$233K – 3223
2015
Q4 		$233K Sell
8,584
-214
-2% -$5.51K ﹤0.01% 1951
2015
Q3 		$192K Sell
8,798
-611
-6% -$15.6K ﹤0.01% 2023
2015
Q2 		$268K Buy
9,409
+865
+10% +$25.2K ﹤0.01% 1999
2015
Q1 		$234K Buy
8,544
+7,060
+476% +$194K ﹤0.01% 1898
2014
Q4 		$39K Sell
1,484
-480
-24% -$14.1K ﹤0.01% 1505
2014
Q3 		$59K Buy
1,964
+168
+9% +$5.2K ﹤0.01% 1469
2014
Q2 		$57K Sell
1,796
-217
-11% -$6.89K ﹤0.01% 1392
2014
Q1 		$65K Buy
2,013
+203
+11% +$7.11K ﹤0.01% 1275
2013
Q4 		$66K Sell
1,810
-11,113
-86% -$432K ﹤0.01% 1140
2013
Q3 		$503K Sell
12,923
-1,160
-8% -$46.7K 0.01% 608
2013
Q2 		$527K Buy
+14,083
New +$556K 0.01% 562

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Envestnet Asset Management's MR Position: Q1 2016 in Review

Envestnet Asset Management sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 8,584 shares — an estimated $233K sold.

Envestnet Asset Management first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $527K in Q2 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Envestnet Asset Management reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Envestnet Asset Management sold 8,584 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $233K.
  • Envestnet Asset Management first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Envestnet Asset Management's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $527K in Q2 2013.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Envestnet Asset Management's 13F filing for Q1 2016, filed 16 May 2016.